19-13286620-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001127222.2(CACNA1A):​c.3436G>A​(p.Val1146Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,526,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000014 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 3.56

Publications

1 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17162156).
BS2
High AC in GnomAdExome4 at 34 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.3436G>A p.Val1146Ile missense_variant Exon 20 of 47 ENST00000360228.11 NP_001120694.1 O00555-8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.3436G>A p.Val1146Ile missense_variant Exon 20 of 47 1 NM_001127222.2 ENSP00000353362.5 O00555-8
CACNA1AENST00000638029.1 linkc.3448G>A p.Val1150Ile missense_variant Exon 20 of 48 5 ENSP00000489829.1 A0A087WW63
CACNA1AENST00000573710.7 linkc.3442G>A p.Val1148Ile missense_variant Exon 20 of 47 5 ENSP00000460092.3 A0A1C7CYY9
CACNA1AENST00000635727.1 linkc.3439G>A p.Val1147Ile missense_variant Exon 20 of 47 5 ENSP00000490001.1 A0A1B0GU81
CACNA1AENST00000637769.1 linkc.3439G>A p.Val1147Ile missense_variant Exon 20 of 47 1 ENSP00000489778.1 A0A1B0GTN7
CACNA1AENST00000636012.1 linkc.3439G>A p.Val1147Ile missense_variant Exon 20 of 46 5 ENSP00000490223.1 A0A1B0GUS3
CACNA1AENST00000637736.1 linkc.3298G>A p.Val1100Ile missense_variant Exon 19 of 46 5 ENSP00000489861.1 A0A1B0GTW2
CACNA1AENST00000636389.1 linkc.3439G>A p.Val1147Ile missense_variant Exon 20 of 47 5 ENSP00000489992.1 A0A1B0GU74
CACNA1AENST00000637432.1 linkc.3448G>A p.Val1150Ile missense_variant Exon 20 of 48 5 ENSP00000490617.1 O00555-2
CACNA1AENST00000636549.1 linkc.3439G>A p.Val1147Ile missense_variant Exon 20 of 48 5 ENSP00000490578.1 B5TYJ1
CACNA1AENST00000637927.1 linkc.3442G>A p.Val1148Ile missense_variant Exon 20 of 47 5 ENSP00000489715.1 A0A1B0GTI4
CACNA1AENST00000635895.1 linkc.3439G>A p.Val1147Ile missense_variant Exon 20 of 47 5 ENSP00000490323.1 A0A384DVW2
CACNA1AENST00000638009.2 linkc.3439G>A p.Val1147Ile missense_variant Exon 20 of 47 1 ENSP00000489913.1 O00555-3
CACNA1AENST00000637276.1 linkc.3439G>A p.Val1147Ile missense_variant Exon 20 of 46 5 ENSP00000489777.1 O00555-5
CACNA1AENST00000636768.2 linkn.3439G>A non_coding_transcript_exon_variant Exon 20 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.3436G>A non_coding_transcript_exon_variant Exon 20 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.0000143
AC:
2
AN:
139758
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000153
Gnomad OTH
AF:
0.000529
GnomAD2 exomes
AF:
0.0000160
AC:
3
AN:
187340
AF XY:
0.0000100
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000227
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000245
AC:
34
AN:
1386298
Hom.:
0
Cov.:
35
AF XY:
0.0000264
AC XY:
18
AN XY:
681724
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30848
American (AMR)
AF:
0.0000300
AC:
1
AN:
33378
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39068
South Asian (SAS)
AF:
0.0000406
AC:
3
AN:
73876
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50272
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5380
European-Non Finnish (NFE)
AF:
0.0000270
AC:
29
AN:
1075356
Other (OTH)
AF:
0.0000175
AC:
1
AN:
57028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000143
AC:
2
AN:
139758
Hom.:
0
Cov.:
29
AF XY:
0.0000298
AC XY:
2
AN XY:
67178
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
36606
American (AMR)
AF:
0.00
AC:
0
AN:
13366
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3362
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4874
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4418
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8650
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
0.0000153
AC:
1
AN:
65412
Other (OTH)
AF:
0.000529
AC:
1
AN:
1892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000354
Hom.:
0
ExAC
AF:
0.0000251
AC:
3
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3
Mar 11, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 16, 2020
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31719132) -

Apr 16, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Mar 21, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Dec 19, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.51
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0093
.;.;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Benign
0.094
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.90
D;D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Benign
0.060
D
MetaRNN
Benign
0.17
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
.;.;.;.;N;.;.;.;.;.;.;.;N;.;.
PhyloP100
3.6
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.28
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.075
Sift
Benign
0.25
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.57
T;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.26
MVP
0.52
MPC
0.046
ClinPred
0.63
D
GERP RS
5.3
Varity_R
0.14
gMVP
0.41
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376365775; hg19: chr19-13397434; COSMIC: COSV64190950; COSMIC: COSV64190950; API